1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martino, S; Samal, BA; Singhakowinta, A | 1 |
| Blumenschein, GR; Bodey, GP; Kavanagh, JJ; Stewart, D; Yap, HY | 1 |
| Rubins, JM; Taylor, SG | 1 |
3 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Breast Cancer
| Article | Year |
|---|---|
PCNU in advanced breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Nitrosourea Compounds | 1983 |
Phase II trail of PCNU in refractory advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Mustard Compounds; Nitrosourea Compounds; Thrombocytopenia | 1982 |
Phase II trial of PCNU in breast carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds | 1989 |